From Medscape Gastroenterology

The Liver Meeting 2016: American Association for the Study of Liver Diseases (AASLD)

November 11 - 15, 2016; Boston, Massachusetts

November 11 - 15, 2016 Boston, Massachusetts

AASLD Cenicriviroc Improves Fibrosis in Patients With Fatty Liver The investigational drug is designed to interrupt the inflammatory cascade that leads to fibrosis and cirrhosis in patients with severe nonalcoholic steatohepatitis (NASH).
Medscape Medical News, November 18, 2016
AASLD Novel Treatment Could Lead to Functional Control of Hep B Nucleic acid polymers block the release of the hepatitis B surface antigen from hepatocytes, boosting the efficacy of standard antiviral therapy, according to an early clinical trial.
Medscape Medical News, November 17, 2016
AASLD Mortality Risk Halved With Statin Use in Alcoholic Cirrhosis Statins reduced mortality risk for patients with compensated and decompensated alcoholic cirrhosis in a retrospective study, and also reduced the risk for decompensation.
Medscape Medical News, November 15, 2016

Medicaid Denial for Hep C Drugs Nearing 50% in Some States Medicaid programs in four states recently refused nearly half of all claims for new hepatitis C drugs, denying impoverished patients access to life-saving medications, physicians say.
Medscape Medical News, Nov 18, 2015
New Treatments Not Enough to Eliminate Hepatitis C Even with powerful new medications, a lack of screening and treatment capacity will make it difficult to eliminate hepatitis C in the United States, new research shows.
Medscape Medical News, Nov 17, 2015
Daclatasvir, Sofosbuvir, Ribavirin Effective in Hep C Type 3 The combination is effective in most patients with hepatitis C genotype 3 infection and cirrhosis, results from the ALLY-3+ trial show.
Medscape Medical News, Nov 19, 2015

Medscape Gastroenterology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentary

Medscape Board at the Podium

Nancy Reau, MD
Rush University Medical Center, Chicago, Illinois
Presentation: Hepatitis C treatment duration: How short can it be?
Date: November 13, 2016

Previous Coverage

Related Resources